Pathogens and Immunity (Jun 2016)

Defining HIV and SIV Reservoirs in Lymphoid Tissues

  • Claire Deleage,
  • Stephen W. Wietgrefe,
  • Gregory Del Prete,
  • David R. Morcock,
  • Xing-Pei Hao,
  • Michael Piatak, Jr.,
  • Julian Bess,
  • Jodi L. Anderson,
  • Katherine Perkey,
  • Cavan Reilly,
  • Joseph M. McCune,
  • Ashley T. Haase,
  • Jeffrey D. Lifson,
  • Timothy W. Schacker,
  • Jacob D. Estes

DOI
https://doi.org/10.20411/pai.v1i1.100
Journal volume & issue
Vol. 1, no. 1
pp. 68 – 106

Abstract

Read online

A primary obstacle to an HIV-1 cure is long-lived viral reservoirs, which must be eliminated or greatly reduced. Cure strategies have largely focused on monitoring changes in T cell reservoirs in peripheral blood (PB), even though the lymphoid tissues (LT) are primary sites for viral persistence. To track and discriminate viral reservoirs within tissue compartments we developed a specific and sensitive next-generation in situ hybridization approach to detect vRNA, including vRNA+ cells and viral particles (“RNAscope”), vDNA+ cells (“DNAscope”) and combined vRNA and vDNA with immunohistochemistry to detect and phenotype active and latently infected cells in the same tissue section. RNAscope is highly sensitive with greater speed of analysis compared to traditional in situ hybridization. Highly sensitive and specific DNAscope detected SIV/HIV vDNA+ cells, including duplexed detection of vDNA and vRNA or immunophenotypic markers in the same section. Analysis of LT samples from macaques prior to and during combination antiretroviral therapy demonstrated that B cell follicles are an important anatomical compartment for both latent and active viral persistence during treatment. These new tools should allow new insights into viral reservoir biology and evaluation of cure strategies.

Keywords